Yamamoto K, Naito Y, Sawada T
Division of Pharmacology, Shionogi Research Laboratories, Shionogi & Co., Ltd., Osaka, Japan.
Nihon Yakurigaku Zasshi. 1987 Sep;90(3):155-62. doi: 10.1254/fpj.90.155.
The sleep-inducing activities of 450191-S (rilmazafone hydrochloride) were compared among two groups of elderly and one group of young rhesus monkeys, and the relationship between blood levels of five active metabolites of 450191-S and sleep-inducing activities was also examined. Oral administration of 450191-S, 1 mg/kg, caused the quick appearance of slow wave deep sleep (SWDS) and its stable continuity in elderly monkeys, and no significant differences in various sleep parameters were observed among the two groups of eight elderly monkeys. An increase of SWDS was always accompanied by a high blood level of active metabolite M-2. On the other hand, in the young rhesus monkey group, the amount of SWDS and its mean continuity were significantly less, and differences were evident in sleep parameters obtained from a nocturnal 14 hr observation. In conclusion, the difference of sleep-inducing activities between elderly and young monkeys seem to be caused by a difference in the blood level of active metabolites of 450191-S, particularly M-2.
在两组老年恒河猴和一组年轻恒河猴中比较了450191-S(盐酸利马扎封)的诱导睡眠活性,并研究了450191-S的五种活性代谢物的血药浓度与诱导睡眠活性之间的关系。对老年猴子口服1mg/kg的450191-S后,慢波深睡眠(SWDS)迅速出现且持续稳定,两组八只老年猴子的各项睡眠参数均未观察到显著差异。SWDS的增加总是伴随着活性代谢物M-2的高血药浓度。另一方面,在年轻恒河猴组中,SWDS的量及其平均持续时间显著较少,并且在夜间14小时观察获得的睡眠参数中差异明显。总之,老年和年轻猴子之间诱导睡眠活性的差异似乎是由450191-S活性代谢物的血药浓度差异引起的,特别是M-2。